{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:05:59Z","timestamp":1789149959242,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"DOI":"10.1007\/s12028-026-02640-x","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:08:35Z","timestamp":1789146515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AMPA Receptor Antagonists in Preclinical Models of Traumatic Brain Injury: A Systematic Review and Meta-analysis of Animal Studies"],"prefix":"10.1007","author":[{"given":"Sylvain","family":"Gourier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gargadennec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis F.","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roquilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Langeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-5741","authenticated-orcid":false,"given":"Marwan","family":"Bouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"11","key":"2640_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas AIR, Menon DK, Manley GT, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol. 2022;21(11):1004\u201360. https:\/\/doi.org\/10.1016\/S1474-4422(22)00309-X.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2640_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4\u20139. https:\/\/doi.org\/10.1093\/bja\/aem131.","journal-title":"Br J Anaesth"},{"issue":"4906","key":"2640_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1126\/science.2567056","volume":"244","author":"AI Faden","year":"1989","unstructured":"Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244(4906):798\u2013800. https:\/\/doi.org\/10.1126\/science.2567056.","journal-title":"Science"},{"issue":"3","key":"2640_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3171\/2009.12.JNS09689","volume":"113","author":"R Chamoun","year":"2010","unstructured":"Chamoun R, Suki D, Gopinath SP, Goodman JC, Robertson C. Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury: clinical article. JNS. 2010;113(3):564\u201370. https:\/\/doi.org\/10.3171\/2009.12.JNS09689.","journal-title":"JNS"},{"issue":"6","key":"2640_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.brainresbull.2011.05.004","volume":"85","author":"P Luo","year":"2011","unstructured":"Luo P, Fei F, Zhang L, Qu Y, Fei Z. The role of glutamate receptors in traumatic brain injury: implications for postsynaptic density in pathophysiology. Brain Res Bull. 2011;85(6):313\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.05.004.","journal-title":"Brain Res Bull"},{"issue":"12","key":"2640_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","volume":"31","author":"DJ Loane","year":"2010","unstructured":"Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010;31(12):596\u2013604. https:\/\/doi.org\/10.1016\/j.tips.2010.09.005.","journal-title":"Trends Pharmacol Sci"},{"key":"2640_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003986.pub2","author":"C Willis","year":"2003","unstructured":"Willis C, Lybrand S, Bellamy N. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Injuries Group, ed. Cochr Database Syst Rev. 2003. https:\/\/doi.org\/10.1002\/14651858.CD003986.pub2.","journal-title":"Cochr Database Syst Rev."},{"issue":"3","key":"2640_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-108337","volume":"16","author":"M Bouras","year":"2026","unstructured":"Bouras M, Costerousse O, Verret M, et al. Excitatory amino acid inhibitors in adults with acute moderate to severe traumatic brain injury: a systematic review and meta-analysis. BMJ Open. 2026;16(3):e108337. https:\/\/doi.org\/10.1136\/bmjopen-2025-108337.","journal-title":"BMJ Open"},{"issue":"3","key":"2640_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405\u201396. https:\/\/doi.org\/10.1124\/pr.109.002451.","journal-title":"Pharmacol Rev"},{"issue":"10","key":"2640_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/neu.2008.0532","volume":"25","author":"JM Spaethling","year":"2008","unstructured":"Spaethling JM, Klein DM, Singh P, Meaney DF. Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate. J Neurotrauma. 2008;25(10):1207\u201316. https:\/\/doi.org\/10.1089\/neu.2008.0532.","journal-title":"J Neurotrauma"},{"issue":"2","key":"2640_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/neu.2015.4373","volume":"34","author":"CR Dorsett","year":"2017","unstructured":"Dorsett CR, McGuire JL, DePasquale EAK, Gardner AE, Floyd CL, McCullumsmith RE. Glutamate neurotransmission in rodent models of traumatic brain injury. J Neurotrauma. 2017;34(2):263\u201372. https:\/\/doi.org\/10.1089\/neu.2015.4373.","journal-title":"J Neurotrauma"},{"issue":"8","key":"2640_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40263-021-00831-y","volume":"35","author":"E Trinka","year":"2021","unstructured":"Trinka E, Lattanzi S, Carpenter K, et al. Exploring the evidence for broad-spectrum effectiveness of perampanel: a systematic review of clinical data in generalised seizures. CNS Drugs. 2021;35(8):821\u201337. https:\/\/doi.org\/10.1007\/s40263-021-00831-y.","journal-title":"CNS Drugs"},{"key":"2640_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.seizure.2022.09.020","volume":"102","author":"A Lavu","year":"2022","unstructured":"Lavu A, Aboulatta L, Abou-Setta AM, et al. Efficacy and safety of perampanel in epilepsy: a systematic review and meta-analysis of randomised controlled trials. Seizure. 2022;102:54\u201360. https:\/\/doi.org\/10.1016\/j.seizure.2022.09.020.","journal-title":"Seizure"},{"issue":"1","key":"2640_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12028-019-00704-9","volume":"31","author":"CJ Ho","year":"2019","unstructured":"Ho CJ, Lin CH, Lu YT, et al. Perampanel treatment for refractory status epilepticus in a neurological intensive care unit. Neurocrit Care. 2019;31(1):24\u20139. https:\/\/doi.org\/10.1007\/s12028-019-00704-9.","journal-title":"Neurocrit Care"},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yebeh.2018.07.004","volume":"86","author":"F Brigo","year":"2018","unstructured":"Brigo F, Lattanzi S, Rohracher A, et al. Perampanel in the treatment of status epilepticus: a systematic review of the literature. Epilepsy Behav. 2018;86:179\u201386. https:\/\/doi.org\/10.1016\/j.yebeh.2018.07.004.","journal-title":"Epilepsy Behav"},{"issue":"10","key":"2640_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40263-013-0091-9","volume":"27","author":"WWQ Hsu","year":"2013","unstructured":"Hsu WWQ, Sing CW, He Y, Worsley AJ, Wong ICK, Chan EW. Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy. CNS Drugs. 2013;27(10):817\u201327. https:\/\/doi.org\/10.1007\/s40263-013-0091-9.","journal-title":"CNS Drugs"},{"issue":"2","key":"2640_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1212\/WNL.0000000000005756","volume":"91","author":"AM Kanner","year":"2018","unstructured":"Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):82\u201390. https:\/\/doi.org\/10.1212\/WNL.0000000000005756.","journal-title":"Neurology"},{"key":"2640_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113222","volume":"327","author":"V Aida","year":"2020","unstructured":"Aida V, Niedzielko TL, Szaflarski JP, Floyd CL. Acute administration of perampanel, an AMPA receptor antagonist, reduces cognitive impairments after traumatic brain injury in rats. Exp Neurol. 2020;327:113222. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113222.","journal-title":"Exp Neurol"},{"issue":"3","key":"2640_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/089771503321532851","volume":"20","author":"T Furukawa","year":"2003","unstructured":"Furukawa T, Hoshino S, Kobayashi S, et al. The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats. J Neurotrauma. 2003;20(3):269\u201378. https:\/\/doi.org\/10.1089\/089771503321532851.","journal-title":"J Neurotrauma"},{"key":"2640_CR20","doi-asserted-by":"publisher","DOI":"10.17605\/OSF.IO\/UB829","author":"M Bouras","year":"2025","unstructured":"Bouras M. AMPA receptor antagonists in animal models of traumatic brain injury: a systematic review. 2025. Publish Online. https:\/\/doi.org\/10.17605\/OSF.IO\/UB829."},{"key":"2640_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, et al editors. Cochrane handbook for systematic reviews of interventions. 1st ed. Wiley; 2019. https:\/\/doi.org\/10.1002\/9781119536604.","edition":"1st ed"},{"key":"2640_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2020. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"Br Med J"},{"key":"2640_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.021.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2640_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2640_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","volume":"35","author":"MR Macleod","year":"2004","unstructured":"Macleod MR, O\u2019Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35(5):1203\u20138. https:\/\/doi.org\/10.1161\/01.STR.0000125719.25853.20.","journal-title":"Stroke"},{"key":"2640_CR26","doi-asserted-by":"publisher","unstructured":"Ritskes-Hoitinga M, Leenaars M, Avey M, Rovers M, Scholten R. Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews. Wiley; 2014:ED000078. https:\/\/doi.org\/10.1002\/14651858.ED000078","DOI":"10.1002\/14651858.ED000078"},{"issue":"1","key":"2640_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. https:\/\/doi.org\/10.1186\/1471-2288-5-13.","journal-title":"BMC Med Res Methodol"},{"issue":"20","key":"2640_CR28","doi-asserted-by":"publisher","first-page":"11699","DOI":"10.1002\/ece3.6806","volume":"10","author":"S Kambach","year":"2020","unstructured":"Kambach S, Bruelheide H, Gerstner K, Gurevitch J, Beckmann M, Seppelt R. Consequences of multiple imputation of missing standard deviations and sample sizes in meta-analysis. Ecol Evol. 2020;10(20):11699\u2013712. https:\/\/doi.org\/10.1002\/ece3.6806.","journal-title":"Ecol Evol"},{"issue":"10","key":"2640_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cesm.12033","volume":"1","author":"E Axon","year":"2023","unstructured":"Axon E, Dwan K, Richardson R. Multiarm studies and how to handle them in a meta-analysis: a tutorial. Cochr Evid Synth Methods. 2023;1(10):e12033. https:\/\/doi.org\/10.1002\/cesm.12033.","journal-title":"Cochr Evid Synth Methods."},{"issue":"3","key":"2640_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"7414","key":"2640_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"Br Med J"},{"issue":"1","key":"2640_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3193725","volume":"2020","author":"F Alqahtani","year":"2020","unstructured":"Alqahtani F, Assiri MA, Mohany M, et al. Coadministration of ketamine and perampanel improves behavioral function and reduces inflammation in acute traumatic brain injury mouse model. BioMed Res Int. 2020;2020(1):3193725. https:\/\/doi.org\/10.1155\/2020\/3193725.","journal-title":"BioMed Res Int"},{"key":"2640_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156457","volume":"139","author":"MK Park","year":"2025","unstructured":"Park MK, Choi BY, Kho AR, et al. L-theanine ameliorates traumatic-brain-injury-induced hippocampal neuronal death in rats. Phytomedicine. 2025;139:156457. https:\/\/doi.org\/10.1016\/j.phymed.2025.156457.","journal-title":"Phytomedicine"},{"issue":"1","key":"2640_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10571-016-0341-8","volume":"37","author":"T Chen","year":"2017","unstructured":"Chen T, Dai SH, Jiang ZQ, et al. The AMPAR antagonist perampanel attenuates traumatic brain injury through anti-oxidative and anti-inflammatory activity. Cell Mol Neurobiol. 2017;37(1):43\u201352. https:\/\/doi.org\/10.1007\/s10571-016-0341-8.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"2640_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cns.13580","volume":"27","author":"T Chen","year":"2021","unstructured":"Chen T, Liu W, Qian X, Xie K, Wang Y. The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3. CNS Neurosci Ther. 2021;27(1):134\u201344. https:\/\/doi.org\/10.1111\/cns.13580.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"2640_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113408","volume":"19","author":"Y Mao","year":"2018","unstructured":"Mao Y, Black AMB, Milbourn HR, et al. The effects of a combination of ion channel inhibitors in female rats following repeated mild traumatic brain injury. Int J Mol Sci. 2018;19(11):3408. https:\/\/doi.org\/10.3390\/ijms19113408.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2640_CR37","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1073\/pnas.93.11.5235","volume":"93","author":"H Bernert","year":"1996","unstructured":"Bernert H, Turski L. Traumatic brain damage prevented by the non-N-methyl-d-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Proc Natl Acad Sci U S A. 1996;93(11):5235\u201340. https:\/\/doi.org\/10.1073\/pnas.93.11.5235.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2640_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02069500","volume":"11","author":"C Ikonomidou","year":"1996","unstructured":"Ikonomidou C, Turski L. Prevention of trauma-induced neurodegeneration in infant and adult rat brain: glutamate antagonists. Metab Brain Dis. 1996;11(2):125\u201341. https:\/\/doi.org\/10.1007\/BF02069500.","journal-title":"Metab Brain Dis"},{"issue":"18","key":"2640_CR39","doi-asserted-by":"publisher","first-page":"10960","DOI":"10.1073\/pnas.95.18.10960","volume":"95","author":"L Turski","year":"1998","unstructured":"Turski L, Huth A, Sheardown M, et al. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998;95(18):10960\u20135. https:\/\/doi.org\/10.1073\/pnas.95.18.10960.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2640_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/08977150152693728","volume":"18","author":"L Belayev","year":"2001","unstructured":"Belayev L, Alonso OF, Liu Y, et al. Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats. J Neurotrauma. 2001;18(10):1031\u20138. https:\/\/doi.org\/10.1089\/08977150152693728.","journal-title":"J Neurotrauma"},{"issue":"2","key":"2640_CR41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12028-024-02079-y","volume":"42","author":"FCP Ribeiro","year":"2025","unstructured":"Ribeiro FCP, De Oliveira NV, Coral GR, et al. Efficacy of N-methyl-d-aspartate (NMDA) receptor antagonists in treating traumatic brain injury\u2013induced brain edema: a systematic review and meta-analysis of animal studies. Neurocrit Care. 2025;42(2):622\u201334. https:\/\/doi.org\/10.1007\/s12028-024-02079-y.","journal-title":"Neurocrit Care"},{"issue":"1","key":"2640_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010152","volume":"14","author":"D Baracaldo-Santamar\u00eda","year":"2022","unstructured":"Baracaldo-Santamar\u00eda D, Ariza-Salamanca DF, Corrales-Hern\u00e1ndez MG, Pach\u00f3n-Londo\u00f1o MJ, Hernandez-Duarte I, Calderon-Ospina CA. Revisiting excitotoxicity in traumatic brain injury: from bench to bedside. Pharmaceutics (Basel). 2022;14(1):152. https:\/\/doi.org\/10.3390\/pharmaceutics14010152.","journal-title":"Pharmaceutics (Basel)"},{"issue":"9","key":"2640_CR43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Singh TG, Kaur A. Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. J Mol Neurosci. 2021;71(9):1725\u201342. https:\/\/doi.org\/10.1007\/s12031-021-01841-7.","journal-title":"J Mol Neurosci"},{"key":"2640_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.wneu.2024.01.084","volume":"185","author":"TJ Orr","year":"2024","unstructured":"Orr TJ, Lesha E, Kramer AH, et al. Traumatic brain injury: a comprehensive review of biomechanics and molecular pathophysiology. World Neurosurg. 2024;185:74\u201388. https:\/\/doi.org\/10.1016\/j.wneu.2024.01.084.","journal-title":"World Neurosurg"},{"issue":"4","key":"2640_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12975-011-0123-z","volume":"2","author":"CM Atkins","year":"2011","unstructured":"Atkins CM. Decoding hippocampal signaling deficits after traumatic brain injury. Transl Stroke Res. 2011;2(4):546\u201355. https:\/\/doi.org\/10.1007\/s12975-011-0123-z.","journal-title":"Transl Stroke Res"},{"issue":"1","key":"2640_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/brain\/awaa321","volume":"144","author":"AAB Jamjoom","year":"2021","unstructured":"Jamjoom AAB, Rhodes J, Andrews PJD, Grant SGN. The synapse in traumatic brain injury. Brain. 2021;144(1):18\u201331. https:\/\/doi.org\/10.1093\/brain\/awaa321.","journal-title":"Brain"},{"issue":"3","key":"2640_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/nep3.70006","volume":"3","author":"RK Rajan","year":"2025","unstructured":"Rajan RK. A comprehensive review on adaptive plasticity and recovery mechanisms post-acquired brain injury. Neuroprotection. 2025;3(3):226\u201352. https:\/\/doi.org\/10.1002\/nep3.70006.","journal-title":"Neuroprotection"},{"issue":"10","key":"2640_CR48","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1523\/JNEUROSCI.5780-10.2011","volume":"31","author":"AN Clarkson","year":"2011","unstructured":"Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G, Carmichael ST. AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci. 2011;31(10):3766\u201375. https:\/\/doi.org\/10.1523\/JNEUROSCI.5780-10.2011.","journal-title":"J Neurosci"},{"key":"2640_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jpba.2017.11.008","volume":"149","author":"D Paul","year":"2018","unstructured":"Paul D, Allakonda L, Sahu A, Surendran S, Satheeshkumar N. Pharmacokinetics and brain uptake study of novel AMPA receptor antagonist perampanel in SD rats using a validated UHPLC-QTOF-MS method. J Pharm Biomed Anal. 2018;149:234\u201341. https:\/\/doi.org\/10.1016\/j.jpba.2017.11.008.","journal-title":"J Pharm Biomed Anal"},{"key":"2640_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ane.12100","volume":"127","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand. 2013;127:19\u201324. https:\/\/doi.org\/10.1111\/ane.12100.","journal-title":"Acta Neurol Scand"},{"issue":"2-3","key":"2640_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-2999(92)90033-Z","volume":"215","author":"JCR Randle","year":"1992","unstructured":"Randle JCR, Guet T, Cordi A, Lepagnol JM. Competitive inhibition by NBQX of kainate\/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. Eur J Pharmacol. 1992;215(2\u20133):237\u201344. https:\/\/doi.org\/10.1016\/0014-2999(92)90033-Z.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2640_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1527-3458.2002.tb00232.x","volume":"8","author":"M Takahashi","year":"2002","unstructured":"Takahashi M, Kohara A, Shishikura J, et al. YM872: a selective, potent and highly water\u2010soluble \u03b1\u2010amino\u20103\u2010hydroxy\u20105\u2010methylisoxazole\u20104\u2010propionic acid receptor antagonist. CNS Drug Rev. 2002;8(4):337\u201352. https:\/\/doi.org\/10.1111\/j.1527-3458.2002.tb00232.x.","journal-title":"CNS Drug Rev"},{"issue":"3","key":"2640_CR53","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72(3):355. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3558.","journal-title":"JAMA Neurol"},{"issue":"2","key":"2640_CR54","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12183","volume":"24","author":"L Yang","year":"2021","unstructured":"Yang L, Wang Y, Zhang C, Chen T, Cheng H. Perampanel, an AMPAR antagonist, alleviates experimental intracerebral hemorrhage\u2011induced brain injury via necroptosis and neuroinflammation. Mol Med Rep. 2021;24(2):544. https:\/\/doi.org\/10.3892\/mmr.2021.12183.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2640_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48802-1","volume":"13","author":"H Yang","year":"2023","unstructured":"Yang H, Ding C, Cheng M, et al. Perampanel attenuates oxidative stress and pyroptosis following subarachnoid hemorrhage via the SIRT3\/FOXO3\u03b1 pathway. Sci Rep. 2023;13(1):21320. https:\/\/doi.org\/10.1038\/s41598-023-48802-1.","journal-title":"Sci Rep"},{"key":"2640_CR56","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuroscience.2018.06.043","volume":"386","author":"M Nakajima","year":"2018","unstructured":"Nakajima M, Suda S, Sowa K, et al. AMPA receptor antagonist perampanel ameliorates post-stroke functional and cognitive impairments. Neuroscience. 2018;386:256\u201364. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.06.043.","journal-title":"Neuroscience"},{"key":"2640_CR57","doi-asserted-by":"publisher","first-page":"1139514","DOI":"10.3389\/fphar.2023.1139514","volume":"14","author":"L Hou","year":"2023","unstructured":"Hou L, Yang J, Zhang X, et al. Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1139514. https:\/\/doi.org\/10.3389\/fphar.2023.1139514.","journal-title":"Front Pharmacol"},{"key":"2640_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108583","volume":"128","author":"DQ Perez","year":"2022","unstructured":"Perez DQ, Espiritu AI, Jamora RDG. Perampanel in achieving status epilepticus cessation: a systematic review. Epilepsy Behav. 2022;128:108583. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108583.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"2640_CR59","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/biom10030464","volume":"10","author":"T Hanada","year":"2020","unstructured":"Hanada T. Ionotropic glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors. Biomolecules. 2020;10(3):464. https:\/\/doi.org\/10.3390\/biom10030464.","journal-title":"Biomolecules"},{"key":"2640_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","volume":"91","author":"GL Sarlo","year":"2021","unstructured":"Sarlo GL, Holton KF. Brain concentrations of glutamate and GABA in human epilepsy: a review. Seizure. 2021;91:213\u201327. https:\/\/doi.org\/10.1016\/j.seizure.2021.06.028.","journal-title":"Seizure"},{"key":"2640_CR61","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.seizure.2025.07.023","volume":"131","author":"Y Sato","year":"2025","unstructured":"Sato Y, Iwami K, Okumura E, et al. Intravenous perampanel in clinical practice: a multicenter prospective registry study. Seizure. 2025;131:334\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2025.07.023.","journal-title":"Seizure"},{"key":"2640_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109369","volume":"147","author":"J Wheless","year":"2023","unstructured":"Wheless J, Wechsler RT, Penovich P, et al. Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: the PERMIT extension study. Epilepsy Behav. 2023;147:109369. https:\/\/doi.org\/10.1016\/j.yebeh.2023.109369.","journal-title":"Epilepsy Behav"},{"issue":"7","key":"2640_CR63","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/cpdd.1107","volume":"11","author":"Z Hussein","year":"2022","unstructured":"Hussein Z, Majid O, Boyd P, Aluri J, Ngo LY, Reyderman L. Intravenous perampanel as an interchangeable alternative to oral perampanel: a randomized, crossover, phase I pharmacokinetic and safety study. Clin Pharm Drug Dev. 2022;11(7):878\u201388. https:\/\/doi.org\/10.1002\/cpdd.1107.","journal-title":"Clin Pharm Drug Dev"},{"issue":"8","key":"2640_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-105190","volume":"15","author":"R Yamamoto","year":"2025","unstructured":"Yamamoto R, Tamura R, Morimoto Y, et al. Perampanel for alleviation of secondary injury in traumatic brain injury (PEACE-TBI): a protocol for a phase-II multicentre randomised clinical trial. BMJ Open. 2025;15(8):e105190. https:\/\/doi.org\/10.1136\/bmjopen-2025-105190.","journal-title":"BMJ Open"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-026-02640-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:08:36Z","timestamp":1789146516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-026-02640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":64,"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1007\/s12028-026-02640-x","relation":{"references":[{"id-type":"doi","id":"10.17605\/OSF.IO\/UB829","asserted-by":"subject"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that no artificial intelligence (AI)-assisted technologies were used in the production of this manuscript.","order":2,"name":"Ethics","label":"Artificial Intelligence","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"OSF.IO\n                      \n                      prospectively registered on 22 April 2025.","order":3,"name":"Ethics","label":"Systematic Review Registration","group":{"name":"EthicsHeading","label":"Ethics"}}]}}